Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 04, 2022 08:30 ET | Source: Future Market Insights Global and Consulting Pvt. Ltd.

Catechins Market To Exceed Valuation Of US$ 30.5 Mn By 2032- FMI

NEWARK, Del, May 04, 2022 (GLOBE NEWSWIRE) -- Total demand in the global catechins market is slated to surge at a 5.7% CAGR, reaching US$ 30.5 Mn by 2032. Catechins are extensively used in...
April 19, 2018 08:30 ET | Source: Plandai Biotechnology, Inc.

Plandai Biotechnology Discusses Cannabis Strategy, Research and Business

LONDON, UNITED KINGDOM , April 19, 2018 (GLOBE NEWSWIRE) -- Plandai Biotechnology Inc. (OTC Markets: PLPL) (the “Company” or “Plandai”), a producer of nutraceutical and highly phyto-available...
May 18, 2017 09:00 ET | Source: Plandai Biotechnology, Inc.

Plandaí Biotechnology's Upcoming Clinical Trial Could Strengthen Case for Phytofare in Treatment of Diabetes

NEW YORK, NY--(Marketwired - May 18, 2017) - Plandaí Biotechnology (OTCQB: PLPL) announced that it will conduct a human clinical trial to study the effectiveness of using its highly bioavailable...
April 02, 2015 09:00 ET | Source: Plandai Biotechnology, Inc.

Plandai Biotechnology's Production Facility Is an Intricate Maze of Proprietary Equipment Producing an Unmistakable Green Tea Extract

NEW YORK, NY--(Marketwired - April 02, 2015) - After years of hard work, Plandaí Biotechnology (OTCQB: PLPL) has everything in place to start realizing the long-time dream of the company's CEO Roger...
March 09, 2015 09:00 ET | Source: Plandai Biotechnology, Inc.

Plandai Biotechnology Producing a More Potent Product Than First Reported

NEW YORK, NY--(Marketwired - March 09, 2015) - Plandaí Biotechnology (OTCQB: PLPL) has probably chosen to err on the side of "under promise and over deliver" when it comes to the bioavailability of...